Trastuzumab without chemotherapy in the adjuvant treatment of breast cancer: subgroup results from a large observational study-Reference-Cited by-同舟云学术

Trastuzumab without chemotherapy in the adjuvant treatment of breast cancer: subgroup results from a large observational study

Published:2018-01-08 Issue:1 Volume:18 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Dall Peter,Koch Thorsten,Göhler Thomas,Selbach Johannes,Ammon Andreas,Eggert Jochen,Gazawi Nidal,Rezek Daniela,Wischnik Arthur,Hielscher Carsten,Schleif Nicolas,Cirrincione Ursula,Hinke Axel^ORCID,Feisel-Schwickardi Gabriele

Funder

Roche Pharma AG, Germany

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-017-3857-5.pdf

Reference26 articles.

1. Figueroa-Magalhaes MC, Jelovac D, Connolly RM, et al. Treatment of HER2-positive breast cancer. Breast. 2014;23:128–36.

2. Coates AS, Winer EP, Goldhirsch A, et al. Tailoring therapies—improving the management of early breast cancer: St Gallen international expert consensus on the primary therapy of early breast cancer 2015. Ann Oncol. 2015;26:1533–46.

3. Smith I, Procter M, Gelber RD, et al. 2 year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomized controlled trial. Lancet. 2007;369:29–36.

4. Perez EA, Romond EH, Suman VJ, et al. Four-year follow-up of trastuzumab plus adjuvant chemotherapy for operable human epidermal growth factor receptor 2-positive breast cancer: joint analysis of data from NCCTG N9831 and NSABP B-31. J Clin Oncol. 2011;29:3366–73.

5. Slamon D, Eiermann W, Robert N, et al. Adjuvant trastuzumab in HER2-positive breast cancer. N Engl J Med. 2011;365:1273–83.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breast Cancer;Geriatric Medicine;2024

2. Breast Cancer;Geriatric Medicine;2023-12-05

4. Adjuvant trastuzumab and vinorelbine for early-stage HER2+ breast cancer;Therapeutic Advances in Medical Oncology;2023-01

5. Breast Cancer;Geriatric Medicine;2023